Interferon regulatory factor 3 protects against adverse neo-intima formation

Area of Science:

• Cardiovascular Biology
• Molecular Mechanisms of Disease
• Immunology

Background:

• Vascular smooth muscle cell (VSMC) proliferation drives neo-intima formation, a key process in vascular disease.
• Interferon regulatory factor 3 (IRF3) is known to inhibit cancer cell and fibroblast growth.
• The specific role of IRF3 in vascular neo-intima formation remained unexplored.

Purpose of the Study:

• To investigate the protective function of IRF3 against the development of neo-intima in a mouse model.
• To elucidate the molecular mechanisms by which IRF3 influences VSMC proliferation and vascular repair.

Main Methods:

• Assessed IRF3 expression in VSMCs following in vivo carotid artery injury and in vitro PDGF-BB stimulation.
• Utilized global IRF3 knockout (IRF3-KO) and SMC-specific IRF3 transgenic mouse models.
• Investigated the interaction between IRF3 and peroxisome proliferator-activated receptor γ (PPARγ) using molecular assays.

Main Results:

• IRF3 expression decreased in VSMCs after vascular injury and PDGF-BB challenge.
• IRF3-KO mice exhibited enhanced neo-intima formation and VSMC proliferation.
• SMC-specific IRF3 overexpression suppressed VSMC proliferation and neo-intima formation.
• IRF3 directly binds to PPARγ, enhancing its transactivation and leading to reduced proliferation markers.

Conclusions:

• IRF3 acts as a crucial inhibitor of VSMC proliferation.
• IRF3 plays a protective role in preventing neo-intima formation post-vascular injury.
• The anti-proliferative effects of IRF3 are mediated through the activation of PPARγ.